GLP-1 research peptides cover the incretin receptor pathway — from the native hormone sequence through engineered long-acting and dual-receptor analogs. This category includes native GLP-1 (7-36) Amide, Semaglutide, and Tirzepatide, each verified by independent HPLC and mass spectrometry.
Standing orders and institutional billing are handled directly by our team.